It's an exciting time to be in cell therapy manufacturing and commercialization, particularly in the oncology space. This year alone, we've seen the US approval of three cell therapy products: Iovance ...
With an increasingly promising roster of approved cell therapies still burdened by complex manufacturing, multiple companies have emerged in recent years on a mission to simplify production for the ...
A little over a year after winning manufacturing certification for its cell therapy factory-in-a-box, South San Francisco’s Cellares has passed another major production milestone. Cellares’ automated ...
As cell therapies scale, developers face a choice: redesign processes for all-in-one systems or manage complex bespoke ...
Officials at Mytos, which is automating cell manufacturing, launched its automated contract development and manufacturing organization (CDMO), offering to overcome one of what they call regenerative ...
Streamlining cell and gene therapy workflows with precise serological pipetting Cell and gene therapies are transforming the ...
Between 2026 and 2028, the U.S. downstream solar community must focus its attention on domestic solar cell production to ...
The AMT designation gives Cellares’ clients using the Cell Shuttle priority review with the FDA leading to accelerated regulatory filings SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the ...
ES Foundry has begun producing solar cells at its 3GW manufacturing plant in South Carolina. The company, which is headquartered in South Carolina, said the facility’s inauguration last week (31st ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results